학술논문

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
Document Type
article
Author
Bojesen, Stig EPooley, Karen AJohnatty, Sharon EBeesley, JonathanMichailidou, KyriakiTyrer, Jonathan PEdwards, Stacey LPickett, Hilda AShen, Howard CSmart, Chanel EHillman, Kristine MMai, Phuong LLawrenson, KateStutz, Michael DLu, YiKarevan, RodWoods, NicholasJohnston, Rebecca LFrench, Juliet DChen, XiaoqingWeischer, MarenNielsen, Sune FMaranian, Melanie JGhoussaini, MayaAhmed, ShahanaBaynes, CarolineBolla, Manjeet KWang, QinDennis, JoeMcGuffog, LesleyBarrowdale, DanielLee, AndrewHealey, SueLush, MichaelTessier, Daniel CVincent, DanielBacot, FrançisAustralian Cancer StudyAustralian Ovarian Cancer StudyKathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)Gene Environment Interaction and Breast Cancer (GENICA)Swedish Breast Cancer Study (SWE-BRCA)Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON)Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE)Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO)Vergote, IgnaceLambrechts, SandrinaDespierre, EvelynRisch, Harvey AGonzález-Neira, AnnaRossing, Mary AnnePita, GuillermoDoherty, Jennifer AAlvarez, NuriaLarson, Melissa CFridley, Brooke LSchoof, NilsChang-Claude, JennyCicek, Mine SPeto, JulianKalli, Kimberly RBroeks, AnnegienArmasu, Sebastian MSchmidt, Marjanka KBraaf, Linde MWinterhoff, BorisNevanlinna, HeliKonecny, Gottfried ELambrechts, DietherRogmann, LisaGuénel, PascalTeoman, AttilaMilne, Roger LGarcia, Joaquin JCox, AngelaShridhar, VijayalakshmiBurwinkel, BarbaraMarme, FrederikHein, RebeccaSawyer, Elinor JHaiman, Christopher AWang-Gohrke, ShanAndrulis, Irene LMoysich, Kirsten BHopper, John LOdunsi, KunleLindblom, AnnikaGiles, Graham GBrenner, HermannSimard, JacquesLurie, GalinaFasching, Peter ACarney, Michael ERadice, PaoloWilkens, Lynne RSwerdlow, AnthonyGoodman, Marc TBrauch, HiltrudGarcia-Closas, MontserratHillemanns, Peter
Source
Nature genetics. 45(4)
Subject
Australian Cancer Study
Australian Ovarian Cancer Study
Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer
Gene Environment Interaction and Breast Cancer
Swedish Breast Cancer Study
Hereditary Breast and Ovarian Cancer Research Group Netherlands
Epidemiological study of BRCA1 & BRCA2 Mutation Carriers
Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers
Chromatin
Telomere
Humans
Breast Neoplasms
Ovarian Neoplasms
Genetic Predisposition to Disease
Luciferases
Telomerase
RNA
Messenger
Oligonucleotide Array Sequence Analysis
Risk Factors
Case-Control Studies
Gene Expression Profiling
Reverse Transcriptase Polymerase Chain Reaction
DNA Methylation
Alternative Splicing
Genotype
Polymorphism
Single Nucleotide
Female
Genome-Wide Association Study
Genetic Loci
Real-Time Polymerase Chain Reaction
Biomarkers
Tumor
Genetics
Breast Cancer
Cancer
Ovarian Cancer
Rare Diseases
Prevention
2.1 Biological and endogenous factors
Aetiology
Biological Sciences
Medical and Health Sciences
Developmental Biology
Language
Abstract
TERT-locus SNPs and leukocyte telomere measures are reportedly associated with risks of multiple cancers. Using the Illumina custom genotyping array iCOGs, we analyzed ∼480 SNPs at the TERT locus in breast (n = 103,991), ovarian (n = 39,774) and BRCA1 mutation carrier (n = 11,705) cancer cases and controls. Leukocyte telomere measurements were also available for 53,724 participants. Most associations cluster into three independent peaks. The minor allele at the peak 1 SNP rs2736108 associates with longer telomeres (P = 5.8 × 10(-7)), lower risks for estrogen receptor (ER)-negative (P = 1.0 × 10(-8)) and BRCA1 mutation carrier (P = 1.1 × 10(-5)) breast cancers and altered promoter assay signal. The minor allele at the peak 2 SNP rs7705526 associates with longer telomeres (P = 2.3 × 10(-14)), higher risk of low-malignant-potential ovarian cancer (P = 1.3 × 10(-15)) and greater promoter activity. The minor alleles at the peak 3 SNPs rs10069690 and rs2242652 increase ER-negative (P = 1.2 × 10(-12)) and BRCA1 mutation carrier (P = 1.6 × 10(-14)) breast and invasive ovarian (P = 1.3 × 10(-11)) cancer risks but not via altered telomere length. The cancer risk alleles of rs2242652 and rs10069690, respectively, increase silencing and generate a truncated TERT splice variant.